Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice.
University Hospital Leipzig, Department of Obstetrics, Leipzig, Germany.
H
H
Stepan
I
I
Herraiz
D
D
Schlembach
S
S
Verlohren
S
S
Brennecke
F
F
Chantraine
E
E
Klein
O
O
Lapaire
E
E
Llurba
A
A
Ramoni
M
M
Vatish
D
D
Wertaschnigg
A
A
Galindo
D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood*; D008565:Membrane Proteins / Q000097:blood*; D000072483:Placenta Growth Factor; D017410:Practice Guidelines as Topic; D011225:Pre-Eclampsia / Q000097:blood* / Q000175:diagnosis; D011237:Predictive Value of Tests; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000097:blood; D011379:Prognosis; D011507:Proteinuria / Q000097:blood*; D015203:Reproducibility of Results; D018570:Risk Assessment; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000097:blood*
D015415:Biomarkers; D008565:Membrane Proteins; C000608036:PGF protein, human; C098069:PIGF protein, human; D011257:Pregnancy Proteins; D000072483:Placenta Growth Factor; C501162:FLT1 protein, human; D040281:Vascular Endothelial Growth Factor Receptor-1